Nebenwirkungen · Tractocile
Tractocile 6.75 mg/0.9 ml solution for injection · Abschnitt 4.8 · PDF-Seite 4
HOS-090067 · Präparat HOS-083977
Possible adverse reactions of atosiban were described for the mother during the use of atosiban in clinical trials. In total 48% of the patients treated with atosiban experienced adverse reactions during the clinical trials. The observed adverse reactions were generally of a mild severity. The most commonly reported adverse reaction in the mother is nausea (14 %).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2022-03-30T02:00:00Z · SHA-256 3b32ea127baee52c67c0a4a2121bc927453966cccc781c0dca9b78f06f6074fe · Passage fad9c59dbd4a38119e0f86cd7b84469eac2aac1076d882f9eeab7f8ef0d0002d · Zeichen 0–366 im Abschnitt